Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
COSM 
Cosmos Health Inc. (COSM)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: COSM (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $3
1 Year Target Price $3
| 0 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -9.94% | Avg. Invested days 25 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 26.18M USD | Price to earnings Ratio - | 1Y Target Price 3 |
Price to earnings Ratio - | 1Y Target Price 3 | ||
Volume (30-day avg) 1 | Beta 4.36 | 52 Weeks Range 0.28 - 1.58 | Updated Date 08/15/2025 |
52 Weeks Range 0.28 - 1.58 | Updated Date 08/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.09 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-08-18 | When After Market | Estimate - | Actual - |
Profitability
Profit Margin -28.26% | Operating Margin (TTM) -6.08% |
Management Effectiveness
Return on Assets (TTM) -14.9% | Return on Equity (TTM) -50.03% |
Valuation
Trailing PE - | Forward PE 52.63 | Enterprise Value 37951336 | Price to Sales(TTM) 0.49 |
Enterprise Value 37951336 | Price to Sales(TTM) 0.49 | ||
Enterprise Value to Revenue 0.71 | Enterprise Value to EBITDA -1.6 | Shares Outstanding 29241700 | Shares Floating 17810378 |
Shares Outstanding 29241700 | Shares Floating 17810378 | ||
Percent Insiders 31.08 | Percent Institutions 3.49 |
Upturn AI SWOT
Cosmos Health Inc.
Company Overview
History and Background
Cosmos Health Inc., formerly known as Polydex Pharmaceuticals Limited, operates as a global healthcare group. They have undergone changes in their business model over the years, focusing on various aspects of healthcare products and services.
Core Business Areas
- Pharmaceuticals: Development, production, and distribution of generic and branded pharmaceutical products.
- Nutraceuticals: Manufacturing and sale of vitamins, supplements, and other health-related products.
- Cosmetics: Sales of cosmetics and personal care products.
- Distribution: Distribution services for pharmaceutical and healthcare products.
Leadership and Structure
Information about the specific leadership team and detailed organizational structure needs to be sourced from official company websites and financial reports. Generally, this includes a CEO, CFO, and various VPs overseeing different departments.
Top Products and Market Share
Key Offerings
- Branded Pharmaceuticals: Includes various prescription and over-the-counter drugs. Market share varies by specific product and region. Competitors include major generic pharmaceutical companies like Teva, Mylan (Viatris), and Sandoz.
- Private Label Nutraceuticals: Vitamins, minerals, and supplements sold under various brand names. Market share depends on the specific retailer or distributor. Competitors include Nature's Bounty, Centrum (GSK), and various private label manufacturers.
- Cosmetics: A range of beauty products. Market share depends on region and products. Competitors include L'Oreal, Unilever, and P&G.
Market Dynamics
Industry Overview
The healthcare industry is experiencing growth driven by an aging population, increasing prevalence of chronic diseases, and technological advancements. Regulatory scrutiny and pricing pressures are key challenges.
Positioning
Cosmos Health Inc. operates in a competitive market with established players. Their competitive advantages may stem from niche product offerings, distribution networks, or cost efficiencies.
Total Addressable Market (TAM)
The global pharmaceutical, nutraceutical and cosmetics market is expected to reach trillions of USD. Cosmos Health Inc. is positioned to capture a share of this through its diverse product portfolio and distribution network. TAM data specifics need to be retrieved from market research reports.
Upturn SWOT Analysis
Strengths
- Diverse product portfolio
- Distribution network
- Potential for growth in emerging markets
Weaknesses
- Relatively small market share compared to major competitors
- Financial performance volatility
- Dependence on key suppliers or distributors
Opportunities
- Expansion into new geographic markets
- Acquisitions of complementary businesses
- Development of innovative products
Threats
- Increased competition
- Regulatory changes
- Economic downturns affecting consumer spending
Competitors and Market Share
Key Competitors
- TEVA
- VTRS
- GSK
- MRK
- JNJ
Competitive Landscape
Cosmos Health Inc. faces strong competition from established players. Their ability to compete depends on product differentiation, pricing strategies, and distribution efficiency.
Growth Trajectory and Initiatives
Historical Growth: Requires analysis of past financial performance to determine growth trends.
Future Projections: Based on analyst estimates (if available). Can be found from financial data sources.
Recent Initiatives: Information can be found from company press releases, investor presentations, and news articles.
Summary
Cosmos Health Inc. operates in a competitive healthcare market. The company has a diverse product portfolio and distribution network. Its success depends on managing competition, adapting to regulatory changes, and executing its growth strategy. Financial performance has been volatile.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC filings (10-K, 10-Q), Market research reports, Financial news articles
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It does not constitute financial advice. Market share data are estimates and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cosmos Health Inc.
Exchange NASDAQ | Headquaters Chicago, IL, United States | ||
IPO Launch date 2012-10-11 | Chairman & CEO Mr. Grigorios Siokas | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 149 | |
Full time employees 149 | |||
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.